Dr. Mazen A. Roshdy, MD

Dr. Roshdy practices at Lehigh Valley Hospital-Cedar Crest in Allentown, Pennsylvania, part of Thomas Jefferson University.

Dr. Roshdy's NPI, 1700129574, was assigned on March 31, 2013. Dr. Roshdy graduated from University of Cincinnati College of Medicine in 2013. Dr. Roshdy holds Pennsylvania license MD474278.

Dr. Roshdy's primary practice is Lehigh Valley Hospital-Cedar Crest, at 1200 South Cedar Crest Boulevard, Allentown, PA 18103 in Lehigh County. The practice phone is (610) 402-8000.

Dr. Roshdy's primary practice is Lehigh Valley Hospital-Cedar Crest in Allentown, Pennsylvania, part of Thomas Jefferson University. Dr. Roshdy is also affiliated with Lehigh Valley Hospital-Pocono. The medical group on file is Lehigh Valley Physician Group (LVPG). Dmand AI also links Dr. Roshdy to 3 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Roshdy practices, 7 sites in all. Vendor and product names are available with a free account.

Vascular surgery is Dr. Roshdy's primary specialty in the NPI Registry, under taxonomy code 2086S0129X. Dmand AI has Dr. Roshdy's licenses on file in 3 states: Pennsylvania, South Carolina and West Virginia.

CMS data shows 2,112 Medicare services from Dr. Roshdy across 20 procedure codes in 2024, for 1,299 Medicare patients. Medicare paid $124,928 for them.

CMS counts 1,299 Medicare patients who saw Dr. Roshdy in 2024. The largest group is 65 to 74, with 522 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 8% are also on Medicaid. Their average risk score is 1.90, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Roshdy's median patient age at 69, with 48% women.

In 2024, Dr. Roshdy wrote 194 Medicare Part D claims for 88 patients. 88% of them were for generic drugs. CMS names the drug for 141 of them, across 4 drugs with 11 or more claims each, at $26,280 in total drug cost. In 2023, CMS named 170 claims across 4 drugs.

Dr. Roshdy accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Roshdy as offering telehealth. CMS counts 12 procedures of removal of nail tissue by Dr. Roshdy, more than 59% of the clinicians it reports for that procedure.

Leg revascularization (restoring blood flow): 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Varicose vein removal: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 4 papers to Dr. Roshdy, published from 2015 to 2022. 2022 was the busiest year, with 2. The most frequent topics are Carotid Stenosis, Constriction, Pathologic and Stents. Dr. Roshdy's most frequent co-authors are Ali F. Aburahma, MD, Matthew Anthony Beasley and Andrew Kook Lee, MD.

CMS Open Payments shows 66 general payments to Dr. Roshdy from 19 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 74% of the total. Medtronic, Inc. paid the most, $1,053.

Dr. Roshdy graduated from University of Cincinnati College of Medicine in 2013.